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Prelabour rupture of membranes(PROM) is defined as 
spontaneous rupture of chorioamnion before the onset of uterine 
contractions.  In PROM there are serious concerns regarding obstetric 
complications as well as perinatal morbidity and mortality. 
Induction of labour is indicated when pregnancy presents a 
threat to well being of mother or child in cases of PROM.  Among the 
various methods of induction of labour prostaglandin(PG) and oxytocin 
are the two major pharmacological agents that are widely used.  Now a 
days there is increasing evidence that prostaglandins can be more 
effective than oxytocin which is the most commonly used drug.  Hence 
this study assumes significance to know about the effectiveness, side 
effects and complications of prostaglandin as compared to oxytocin in 
PROM patients. 
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1. To compare the efficacy of endocervical prostaglandin E2 
gel and intravenous oxytocin in the  induction of labour in term 
pregnancies with prelabour rupture of membranes. 
2. To compare the induction - delivery interval and the 
mode of delivery in each group. 
3. To compare the fetal outcome and the occurrence of fetal 
complications in both groups. 
 4.To study the maternal complication in both groups 
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           Fetal Membranes Embryology: 
Chorion is developed from parietal extra embryonic 
mesoderm (on the inside) and the overlying trophoblast (on the 
outside). 
Amnion is constituted by amniogenic cells forming the wall of 
the amniotic cavity.  These cells are derived from the trophoblast.  1 
 Anatomy 
The human fetal membranes is composed of inner amnion  
and outer chorion.2 
 Amnion  
It is the innermost fetal membrane.  Amnion is a vascular 
structure.  It provides almost all of the tensile strength.2 
Amnion Structure 2 
Inner to Outer 
1. Single layer of cuboidal epithelial cells. 
2. Basement membrane. 
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3. Acellular compact layer which is composed of interstitial 
collagens I, IIIandV. 
4. Row of fibroblast like mesenchymal cells. 
5. Acellular Zona  Spongiosa 
As a site of Prostaglandin production, the amniotic 
epithelium participates in the final common pathway of initiation of 
labour. 
Chorion is a thick opaque friable avascular structure of 
thickness varying from 0.02 - 0.2 mm. 
 
Amniotic Fluid - Origin  
In early pregnancy, amniotic fluid is an ultra filtrate of 
maternal plasma.By the beginning of the second trimester, it consists 
largely of extra cellular fluid that diffuses through the fetal skin.After 20 
weeks, amniotic fluid is composed largely of fetal urine. Pulmonary 
fluid contributes a small proportion. 
Functions of Amniotic Fluid 3 
1. Cushioning effect to the fetus. 
2. During labour it forms hydrostatic wedge, which helps in 
dilatation of the cervix. 
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3. When amniotic membrane is intact, it prevents 
interference of placental circulation during uterine contractions. 
4. It prevents ascending infection to the uterine cavity at the 
end of the first stage of labour by flushing and bactericidal action. 
PROM (Prelabour rupture of membranes )  
Prelabour rupture of membranes  (PROM) is defined as 
spontaneous rupture of the chorioamnion before the onset of uterine 
contractions and irrespective of whether this rupture occurs before 
term, at term or postterm4.  If PROM occurs before 37 completed 
weeks of pregnancy it is referred to as a preterm prelabour rupture of 
membranes (PPROM). 
In these cases there is serious concern regarding the 
obstetric complications including perinatal morbidity and mortality. 
Incidence  
PROM occurs in 4 - 18% of pregnancies - majority occurring 
after 37 completed weeks.4 In another study incidence is 2.7 - 17% of 
all pregnancies and in most cases happens spontaneously and without 
apparent cause. 5 
PPROM which occurs in 2% of all pregnancies is 
responsible for nearly 50% of the preterm deliveries and consequent 
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10% of perinatal mortality. 4The incidence of PROM varies from 2.6 - 
14%. 
 
Pathology of PROM 
There is thinning of the epithelium at the site of rupture  and 
decrease in its tensile strength.  Collagen sheets and fibril bundles  are 
dissolved and replaced by amorphous material signifying disorientation 
of the extra cellular matrix .6 
A loss in membrane integrity is associated with a reduction 
in type III collagen which is brought about by enzymatic proteases. 
Decidual prolactin may induce osmolarity changes in the 
amniotic fluid.  These may affect the viscous component of the 
membranes. 
Associated Factors 6 
1. Recurrent genitourinary infections. 
2. Malnutrition. 
3. Over distension (Multiple gestation, hydraminos). 
4. Over exertion. 
5. Poor hygiene. 
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6. Stress. 
7. High Parity. 
8. Anemia. 
9. Incompetent os. 
10. Coitus. 
11. Diet and habits (low levels of  Ascorbic acid, Copper, 
Zinc). 
12. Smoking. 
13. Iatrogenic trauma (Amniocentesis, fetoscopy). 
14. Genetic disorders (Ehlers - Danlos syndrome). 
15. History of PROM / Preterm delivery in previous 
pregnancy. 
16. Low Socioeconomic status. 
Diagnosis  6 
1. Besides the history of leak or sudden gush of fluid from 
the vagina,speculum examination may reveal the presence of liquor in 
the vagina. 
2. Nitrazine Test :  
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Accurate in 90 - 98% of cases.  It detects the alkaline pH of 
the amniotic fluid (7 - 7.5) as compared to vaginal or cervical 
secretions (4.5 - 5.5) 
3. Fern Test :  
Accurate in 85 - 98% of cases.  The fluid is dried on a slide 
and observed under microscope.  It produces fern pattern due to 
crystallization of Nacl in amniotic fluid. 
4. Nile blue sulphate test :  
The presence of desquamated cells from the fetal skin which 
stains orange indicates ruptured membranes. 
5. Amnioscopy : May reveal absence of membranes. 
6. Diamine oxidase test :  
The decidual cells which enter aminotic fluid can be detected 
by paper strips. 
7. Intra amniotic dye instillation :  
Instillation of indigo carmine, evansblue, sodium fluroscein is 
followed by examination of the vaginal fluid on the pad for the 
presence of the dye after few hours. 
8. Heat / Evaporation test :  
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Endo cervical material is heated on a glass slide and color of 
the residue is noted.  A white residue indicates the presence of 
amniotic fluid and a brown one, its absence. 
9. Single measurement of AFP in vaginal secretion - recent 
one. 
10. Detection of fetal fibronectin in  vaginal fluid. 
11. The presence of insulin like growth factor binding   
protein - 1 in vaginal secretions. 
12. Ultra sound examination for quantity of liquor. 
 
Maternal and fetal complications 5 
1. Chorio amnionitis ( 4.2%  - 10.5%) 
2. Abruptio Placenta( 6%) 
3. Hyaline membrane disease. 
4. Pulmonary hypoplasia 
5. Fetal Distress 
6. Postural deformities 
7. Neonatal infections  
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- Septicemia 
- Meningitis 
- Pneumonia 
- Pyoderma 
- Umbilical Sepsis  
- Conjuctivitis.  
Management :  
Spontaneous rupture of membranes occurs relatively 
frequently.  It should also be kept in mind that unlimited conservation is 
associated with increased maternal and neonatal morbidity 6 
Some centres advocate immediate induction of labour 
because of reported association of increased maternal and fetal 
infections with increased latent period. 
Rise in perinatal morbidity with increase in latent period 
makes early decision mandatory . There should be no delay in 
immediate induction if fetus is judged to have good chance of extra 
uterine survival. 
 
 
 11
Problems in term PROM with unfavourable cervix are  
1) Risk of infection when induction is postponed.  
  2)  Failed induction resulting in increased caesarean 
section rates. 
 
 
                          Management of Term PROM  4 
                          ↓ 
 
Confirm diagnosis and obtain high vaginal swab for culture 
                          ↓ 
 
Sterile speculum examination only, digital examination to 
assess cervix if thought to be labouring 
 
                           ↓ 
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Assess maternal and fetal well being  
(Assess colour / nature of liquor,  presentation, CTG, Maternal 
observation 
                 ↓                     ↓                                             ↓                                 ↓                                  
  
MSAF                 Malpresentation        Maternal Pyrexia        All  normal 
           +/- Abnomal CTG                ↓                           ↓              
             ↓                                                                                                                                             
   Expedite                Discuss most                      Investigations                
             delivery                    appropriate                          antibiotics  
              mode of delivery                  Expedite delivery 
                         All normal 
↓ 
Favourable cervix                          unfavourable cervix    
                      ↓                                        ↓                          ↓           
        Induction and deliver                        Immediate               Expectant   
                                                                  induction           management                                 
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Patients delivered 24 hrs after PROM had significant risk of 
infection.  Infection related to PROM depends on number of  per 
vaginal examinations and time taken between first  per vaginal 
examinations  and delivery. 
Unless the mother is grossly neglected mortality due to 
PROM should not occur.  Even morbidity is almost negligible.  But still 
development of Chorioamnionits or overt infection is associated to 
higher maternal morbidity and rarely death. 
In the presence of infection abnormal labour pattern is 
common and the chances of operative delivery are increased. 
Expected Problems in induction. 
1. Failure of induction 
2. Unforeseen disproportion 
3. Prematurity 
4. Sepsis 
5. Cord Compression 
6. Accidental haemorrhage. 
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Cervical Scoring System 4 
 
 
Bishop’s score (Bishop 1964) 
 0 1 2 3 
Dilatation (cm) 0 1 - 2 3 - 4 >4 
Effacement (%) 0 - 30 40 - 60 60 - 70 80+ 
Station (cm) - 3  - 2 - 1 / 0 +1 / +2 
Consistency  Firm Medium Soft  
Position Posterior 
Mid - 
Position 
anterior  
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Modified Bishop’s Score (Calder 1974) 
 
 0 1 2 3 
Dilatation (cm) < 1 1 - 2 2 - 4 > 4 
Effacement (cm) > 4 2 - 4 1 - 2 < 1 
Station (cm) - 3  - 2 - 1 / 0 
+1 / 
+2 
Consistency  Firm Average Soft - 
Position Posterior 
Mid - 
Anterior 
- - 
 
Chemistry 6 
Prostaglandins are family of polyunsaturated 20 Carbon fatty 
acids containing a cyclopentane ring and two aliphatic side chains. 
Chemically they are derivatives of the Prostanoic acid. Prostaglandins 
are divided into groups A - I according to the difference in the structure 
of the five membered cyclopentane ring. 
On its release from membrane phospholipids, arachidonic 
acid is metabolized by two types of enzymes.  The enzyme           
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cyclo-oxygenase converts it to an unstable prostaglandins 
endoperoxide PGG2.  This is converted immediately to the PG 
endoperoxide PGH2.  The PGH2 is enzymatically converted into  
stable substances PGE2, PGF2, PGD2. 
The prostaglandin used in the present study is a natural 
prostaglandin which  induces cervical ripening when applied 
endocervically.  There is little or no evidence of storage in cervical 
tissue.  They are rapidly metabolized in the cervical tissue via 15 
hydroxy prostaglandin dehydrogenase and 13  reductase enzymes. 
PGE2 causes cervical ripening and relaxes cervical muscle 
while PGF2acontracts uterine smooth muscle.  Hence PGE2 is used in 
the present study. 
Oxytocin  
Oxytocin is an octapeptide synthesized in the neurons of the 
paraventricular and supraoptic nuclei of the hypothalamus and 
transported and stored in the neuro hypophysis.  It has a half life of 3 - 
10 minutes. 
In myometrial cells, oxytocin increases the activity of  
phosphodiesterases, bringing about a decrease in cyclic AMP 
concentration that  in turn causes release of calcium from the 
endoplasmic reticulum..  The increased concentration of free intra 
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cellular calcium causes contraction of myometrial cells and oxytocin 
also promotes the formation of gap junctions necessary for the orderly 
propagation and synchronization of  uterine contractions. 
Oxytocin should always be given by continuous intravenous 
infusion using a pump capable of precisely delivering small amounts of 
medication. 
The main problems associated with oxytocin administration 
are hyper stimulation and neonatal hyperbilirubinemia. 
Many studies have been done on safety and efficacy of 
prostaglandin E2.  It  has been used as oral tablets, pessaries as well 
as intracervical gel in various studies 
In a study by Egarter et al PGE2 containing gel was tested 
with relation to its   safety and efficacy. Fifty seven percent of the 
nulliparas and 71% of the multiparas with a modified Bishop-score of 
smaller than or equal to 5 could be delivered within 12 hours of the first 
gel-application. The rate of operative deliveries in this group of low risk 
patients was low (4.1% in nulliparas and 1.9% in multiparas)7.  
The efficacy of prostaglandin gel was studied by Bredow et 
al in 30 gravida at or near term with an unripe score of the cervix. In 11 
cases labour had started with intracervical prostaglandin gel, the 
Bishop-score of the other gravida was improved in the mean   from   
2.5 +/- 1.1 to 5.5 +/- 1.7. When the induction was carried out with 
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PGE2, the rate of success rose to 5 of 9, compared to infusion of 
oxytocin in 6 of 10 cases.8. 
 In a study done by Ekman et al which included fifty-four 
women, 37 of them (70%) who received prostaglandin gel had cervix 
ripened within 5 hours and seven of them were in labour at that time.9  
                 In a study by Gonen et al intracervical 
prostaglandin E2 (PGE2) gel is compared with conservative 
management for induction of labour in patients with premature rupture 
of the membranes (PROM) at term and with an unripe cervix. Of the 
patients receiving PGE2, 93% began labour after a single application, 
and the mean interval between prostaglandin application and delivery 
was 6.6 hours. In the conservative group, only 57% began labour 
within 24 hours, and more than half of them required augmentation 
with oxytocin10      
Many studies have compared prostaglandin E2 with a 
placebo. One hundred fifty-five nulliparas at term with poor cervical 
scores (modified Bishop score below 6 of 10) and premature rupture of 
membranes (PROM) were recruited in a double-blind, placebo-
controlled randomized trial. Women receiving a PG pessary were 
significantly less likely to require stimulation of labour at the end of 12 
hours than were those given a placebo pessary (37 versus 58%,         
P =0 .002). The mean time between admission to study and delivery 
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was significantly shorter in the PG group compared with the placebo 
group11   
A randomized double-blind, placebo-controlled study done 
by Bernstein et al included 107 women . Compared to controls 
receiving placebo gel only, the group receiving prostaglandin E2 gel 
had significant increase in their cervical Bishop scores, shorter 
induction-to-delivery intervals, shorter time requiring use of oxytocin, 
and more successful labour induction without oxytocin.12       
Oral prostaglandin was compared with intravenous oxytocin 
in different studies.In a randomized prospective study, the use of 
intravenous oxytocin with oral PGE2 tablets for stimulation of labour in 
cases of premature rupture of membranes (PROM) before term were 
compared by El-Qarmalawi et al. Labour induction was successful in 
96% of patients in the PGE2 group compared with 84% in the oxytocin 
group13. 
  A clinical trial involving 60 patients was conducted to 
assess the relative efficacy of intravenous oxytocin and oral 
prostaglandin E2 in ripening the unfavourable cervix, when given as a 
priming dose on the day before induction of labour. There was 
significant improvement in the Bishop score, and the subsequent 
induction-delivery interval following priming with prostaglandin. This 
improvement appeared to be dose-related.14 
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  In a study by Lange et al Prostaglandin E2-tablets were 
compared to intravenous oxytocin for the stimulation of labour in 201 
patients at or near term, with premature spontaneous rupture of the 
membranes without labour activity for 6 hours after the escape of fluid.  
A significant difference was found in the stimulation-delivery time, in 
favor of intravenous oxytocin.15 
Twenty  nulliparous term pregnant women with premature 
rupture of the membranes and unfavorable cervical states were 
randomly given either oxytocin intravenously or 4 mg prostaglandin E2 
in gel intravaginally. One of ten women receiving oxytocin had a 
favorable cervical state within five hours and vaginal delivery within 24 
hours after the start of the infusion compared with six of ten women 
after prostaglandin E2 gel application. This difference was found to be 
statistically significant (P less than 0.01). The number of instrumental 
deliveries was nine (four caesarean sections and five vacuum 
extractions) in the oxytocin-treated patients compared with only two 
vacuum extractions in women who received  prostaglandin E2 gel. This 
difference is also statistically significant (P less than 0.01).16  
In a study which included one hundred nulliparas at term 
were randomly given oxytocin intravenously or prostaglandin E2 
(PGE2) gel (0.5 mg PGE2) intracervically when the cervix was 
unfavorable, 53% of the patients could be delivered with PGE2 gel, 
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compared with 31% when oxytocin was given. In patients with a highly 
unfavorable cervix this difference was significant (P less than 0.02).17.  
  A multicentric  trial conducted in the United States and 
Canada, included 538 women; 277 treated with PGE2 gel and 261 
controls with oxytocin, with initial Bishop scores of < or = 4. Compared 
to controls, PGE2 recipients had significant improvement in cervical 
Bishop scores (P < 0.01) and a high rate of labour (47.4% vs. 9.6%, P 
< .001) during the 12-hour ripening period18                    
A prospective randomized trial was performed on one 
hundred primigravid women by Ashrafunnessa et al  between 37 and 
42 weeks of gestation. The Modified Bishop Score (MBS), interval 
between IOL and onset of labour and the duration of labour after 
insertion of PGE2 gel was significantly different from those of oxytocin 
infusion group. The proportion of emergency Caesarean Section (CS) 
was high in the oxytocin infusion group than that of in the prostaglandin 
group. There was also no significant difference regarding the 
acceptability of both the induction methods.19 
  In another study which included 49 patients in each series 
the over-all success rate with PGE2 gel is 82 per cent; with oxytocin, 
65 per cent but there was no difference in the duration of labour in 
successful inductions with PGE2 or oxytocin.20  
  Papageorgiou et al studied labour characteristics after 
intracervical application of 0.5 mg prostaglandinE2 gel (n = 83) versus 
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intravenous administration of oxytocin (n = 82).  The induction to 
delivery time as well as the total oxytocin dose were significantly 
reduced in the PGE2 group (p < 0.001). Caesarean sections, 
instrumental deliveries and fetal distress had the same frequency, but 
the failures of trial were significantly higher in the oxytocin group than 
in the PGE2 group (20.7 vs. 6%, p < 0.01).21 
      Rayburn et al compared prostaglandin E2 (PGE2) gel 
and oxytocin for the initiation of labour in term pregnancies with a 
moderately favorable cervix (Bishop score 5-8). Compared with a 
matched group, 48 cases treated with PGE2 gel (2.5 mg intravaginally) 
required significantly less or no oxytocin, had shorter first stages of 
active labour, and had no increased risk of uterine hyperstimulation or 
caesarean section.22. 
Goeschen studied the influence of endocervical application 
of 0.4 mg prostaglandin E2 (PGE2) gel on the clinical outcome of 
pregnancies of at least 36 weeks' duration complicated with premature 
rupture of the membranes (PROM) and unripe cervix, (modified Bishop 
score of 7 or less). There were 579 women in the study. The clinical 
outcome was significantly better in the PGE2-treated patients than 
oxytocin-infused patients. PROM to delivery interval and the incidence 
of operative deliveries were significantly reduced.23 
A prospective study was undertaken by Herabutya et al to 
evaluate the safety and efficacy of a 3 mg prostaglandin E2 (PGE2) gel 
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applied intracervically. The 3 mg PGE2 gel was found to be an 
effective method of cervical ripening in primigravida and multigravida 
with a success rate of 76 and 86.8 per cent after the first application to 
96.4 and 97.4 per cent after third application respectively.24  
In a study by Vrtacnik-Bokal et al comparing prostaglandin 
E2 and oxytocin infusions for induction of labour in primiparas at term 
with an unripe cervix and premature rupture of fetal membranes Each 
group contained 17 nulliparas. In the first group the labour was induced 
with the prostaglandin E2 (PGE2) infusion, in the second group the 
oxytocin infusion was used. The results of both groups were 
compared. PGE2 was found to be effective in labour induction; the rate 
of caesarean sections was 18.75% in the first group and 29.41% in the 
second group. The PGE2 drug was found to be safe for the fetus and 
also well tolerated by pregnant women.25 
In a study by Ray et al one hundred and forty patients were 
randomized to one of three study groups: prostaglandin E2, placebo, 
or oxytocin. Patients receiving prostaglandin E2 were found to be  
more likely to be in labour after one suppository and delivered without 
the addition of oxytocin when compared with placebo.26  
  A double-blind clinical trial consisting of  200 patients done 
by Pollnow et al Two intravaginal, 4 mg prostaglandin E2 gel 
applications administered 4 hours apart were compared with 10 hours 
of low-dose oxytocin (2 mU/min).  There were no difference in parity, 
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initial Bishop scores, estimated gestational ages, indications for 
induction, or birth weights. Prostaglandin E2 gel was significantly better 
(p < 0.0001) at achieving a change in the Bishop score of 3 or more. 
The number of successful inductions was significantly greater (p < 
0.0003) and the mean time to active labour was significantly shorter (p 
< 0.0002) in the prostaglandin E2 group than in the oxytocin group.27 
In a study by Zehradnik et al comparing prostaglandin E2 gel 
with oxytocin, 100 gravida were included. In 46 of 50 women (92%) 
treated with prostaglandin E2 gel there was an increase in the Bishop 
score of at least three points. The frequency of caesarean sections 
was 10% (n = 5) in the PGE2 gel group and 12% (n = 6) in the oxytocin 
group.28  
   In a study by Atad et al thirty subjects were included in the 
PGE2 gel group, 30 in the oxytocin group and 35 in the Atad Ripener 
Device group. The postpartum course was comparable in all. The 
change in Bishop score and induction-to-delivery interval in the PGE2 
and Atad Ripener Device groups was significantly better than in the 
oxytocin group.29 
  Forty five  term pregnant patients with premature rupture of 
membranes were randomized into two groups PGE2 gel(20) and 
oxytocin (20).   Caesarean section rates were 24% in the oxytocin 
group and 5% in the other (p < 0.05).  The mean rupture to delivery 
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time was 12.6 +/- 4.4 hours in the oxytocin group and 16.5 +/- 4.5 
hours in the prostaglandin group (p < 0.01).30 
Cabrol et al studied intracervical PGE2 gel application, as 
compared to placebo, for priming of the cervix in 208 patients at term 
The cervical ripening success rate is significantly higher in the treated 
group (58.6%) than in the control group (27.8%; p = 0.0001):31   
Granstrom et al studied sixty-one term pregnant women, 29 
nulliparous (Group A) and 32 multiparous (Group B) with unfavorable 
cervix and premature rupture of the membranes (PROM) were given 3 
mg PGE2 in suppository form for cervical ripening and labour 
induction. Five hours after starting the treatment, 12 women of the 29 
in Group A and 21 of the 31 in Group B had a favorable cervix and 
established labour.32 
One study by Kuvacić et al compared oral prostaglandin E2, 
prostaglandin E2 gel and intravenous oxytocin. Two hundred and one 
patients at or near term, with premature spontaneous rupture of the 
membranes were included. One hundred and thirty eight (138) women 
received PGE2 peroral tablets, 14 intracervical PGE2 gel, and 67 
oxytocin intravenously. There were 73.2% vaginal deliveries in the 
group that received PGE2 per oral, 77.5% in the group that received 
oxytocin, and 92.9% in the group that was given intracervical gel. The 
difference were significant.33 
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  In one study intravenous oxytocin was compared with          
intravenous prostaglandin E2  by Steiner et al in the induction of 
labour.  Labour duration was significantly shorter in the PGE2 group (2 
hrs., 36 mins.) than among the oxytocin group (3 hrs., 26 mins.). PGE2 
patients showed a significantly faster cervical dilatation and a 
significantly shorter interval between dilatation and delivery (p .05).34 
   Though many studies have reported significant                        
improvement with prostaglandin E2  some studies have not reported 
any significant improvement compared to intravenous oxytocin . 
Ninety-four nulliparous women with a poor cervical score (less than 6) 
who had premature rupture of membranes at term were studied. One 
group received immediate stimulation of labour with oxytocin infusion. 
The second group received two prostaglandin E2 (PGE2) 3-mg 
pessaries 4 hours apart, followed by oxytocin infusion, if necessary. 
The use of PGE2 3-mg pessaries 4 hours apart, followed by oxytocin 
infusion if necessary, did not confer any benefit over the use of 
intravenous oxytocin in obstetric or neonatal outcome35. 
  Another study by Herabutya et al included forty-seven 
nulliparous term pregnant women with PROM and unfavorable cervix, 
were randomly divided into 23 patients who were observed for four 
hours then followed by intravenous oxytocin, and 24 patients who were 
given 3 mg PGE2 gel intravaginally then followed by intravenous 
oxytocin four hours later. No statistically significant difference was 
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observed between the two treatment groups with regard to Bishop 
score four hours after observation, intravenous oxytocin to delivery 
time, Apgar score at 1 and 5 minutes and maternal puerperal 
complications in both groups36. 
In another study by Jackson et al which included 158 women 
were randomized to receive either two intracervical doses of 0.5 mg 
prostaglandin E2 gel 6 hours apart or 12 hours of intravenous oxytocin 
up to 4 mlU/min. There was no difference between the prostaglandin 
E2 and low-dose oxytocin groups in the likelihood of being in labour or 
having a Bishop score favorable for induction after ripening (64.2% vs 
52.0%, p = 0.12) or in the incidence of vaginal delivery (75.9% vs 
74.7%).Prostaglandin E2-treated patients were delivered sooner (20.2 
+/- 8.1 hours vs 25.0 +/- 10.5 hours, p = 0.002). Among delivered 
patients the likelihood of vaginal delivery within 24 hours was greater 
with prostaglandin E2 ripening (63.7% vs 47.2%, p = 0.04), but there 
was no difference at 36 hours  (76.2% vs 75.0%).37  
  In a study by McCaul et al, 96 women with PROM and an 
unfavorable cervix were randomized into one of three treatment 
groups: oxytocin induction, vaginal prostaglandin E2 gel followed by 
oxytocin, or expectant management. Length of labour, caesarean 
section rate, and maternal/neonatal morbidity were not significantly 
different.38. 
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In another study by Magann et al,  ninety-nine women were 
included.  No difference were detected among prostaglandin E2 gel, 
estrogen, and oxytocin in relation to cervical ripening in patients with 
an unfavorable cervix at term who require an induction of labour.39 
In a study by Anderson et al which included 88 patients  
prostaglandin E2 vaginal tablets were compared with intravenous 
oxytocin for induction of labour in premature rupture of the membranes 
and immature cervix. The   results did not reveal any significant 
difference in the numbers of successful inductions regardless of the 
Bishop score at the commencement of stimulation.40 
  Few studies have reported complications such as 
polisystoly , chorioamnionitis etc.. for prostaglandin whereas others 
have not. In a study by Kuvaic et al the outcome of stimulation of 
labour in 219 primiparous patients with more than 6 hours following a 
premature rupture of the membranes, and with unripe cervix, without 
the established labour were studied. Uterine polisystoly was 
encountered in 10.9% labours after peroral stimulation, in 7.1% in the 
gel group and in 1.5% in the oxytocin group, and perinatal asphyxia in 
16.7%, 7.1% and 13.4%, respectively peroral stimulation predisposes 
to uterine polisystoly. Intracervical application of PGE2 gel is 
suggested as the method of choice in primigravid patients with a 
premature rupture of the membranes and the unripe cervix.33 
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  Malik et al,  randomized 118 patients to receive either 
endocervical 0.5 mg of PGE2 gel (study group) or immediate oxytocin 
induction of labour (control group). The rates of clinical amnionitis were 
5.3% in the PGE2 group and 8% in the control group. Endometritis 
developed in 1.7% of PGE2 patients and 3.2% of controls. These 
difference in maternal infection rates were not statistically significant.41 
   In a study of one hundred fifty-five nulliparas at term with 
poor cervical scores (modified Bishop score below 6 of 10) and 
premature rupture of membranes (PROM), comparing PGE2gel with a 
placebo the caesarean delivery rates in the two groups were similar, 
and there were no significant difference in neonatal outcome.11   
  In a study which included 158 women uterine 
hyperstimulation and fetal distress during ripening occurred only in the 
prostaglandin E2 group, at a rate of 4.8%37. 1,472 births with a medical 
indication were induced in a multicenter-study. With a Bishopscore < 5 
prostaglandin E2 gel intracervical and with a score between 5 and 8 
vaginal tablets were used for induction.The APGAR-score one minute 
post partum was < 8 in 10.8 per cent of all neonates. This part was 
nearly the same in the gel- and in the tablet group (p > 5%).42.  
  A prospective randomized trial was performed on one 
hundred primigravid women between 37 and 42 weeks of gestation 
with singleton pregnancy.  But the Apgar Score at 1 and 5 min had 
shown no statistically significant difference. 19  
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In a study which studied the effects of oral prostaglandin in 
49 patients in each series, nausea and diarrhea are more common 
with PGE2 but in only one case was this severe enough to warrant 
discontinuing the medication. One case of uterine hypertonus occurred 
in each series. No serious harmful effects on mother or fetus were 
noted with PGE2.20  
In a study comparing intracervical application of 0.5 mg 
prostaglandin (PG) E2 gel (n = 83) versus intravenous administration 
of oxytocin (n = 82), more neonates in the oxytocin group had 5-min 
Apgar scores < 7 (p < 0.05).21 In the study which included 579 women  
no adverse effects on the neonates were observed and the incidence 
of neonatal infection declined.23 
  In a study comparing oral prostaglandin with intravenous 
oxytocin side effects with prostaglandin E2 were mostly mild 
gastrointestinal ones. A significantly higher incidence of foetal distress 
was observed with intravenous oxytocin (15%) as compared to 
prostaglandin E2 (3.33%)43. In a study comparing  prostaglandin gel 
with intravenous oxytocin  with 17 nulliparas in  each group no 
incidence of uterine hyperactivity was recorded. All newborns in the 
first group were in good condition. 25:. 
In another study with  one hundred and forty patients the 
incidence of maternal infection was lowest in patients with labour 
induced by prostaglandin E2.26 In a double-blind clinical trial involving 
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200 patients comparing prostaglandin gel and intravenous oxytocin 
there were no difference between patient groups in the caesarean 
section rate, meconium staining, hyperstimulation, and Apgar scores.27 
In another study involving 100 gravida  no severe side 
effects were observed during and after PGE2 treatment, in either the 
mothers or the children.28 In  a retrospective review of the efficacy and 
safety of prostaglandin E2  involving 146 women with PROM  the 
caesarean rate was 12%. Chorioamnionitis developed in 6.8% of the 
study group and endometritis in 2%. Neonatal complications were 
limited to two with low Apgar scores (less than 7 at 5 minutes)44. In a 
study of 208 patients at term signs of myometrial hypercontractility 
were observed in the PGE2 treated group as compared to the control 
group (p = 0.01).31 
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The present study is carried out at Raja Sir Ramasamy 
Mudaliar hospital, Chennai during the period  2006 - 2008.  All 
pregnant women who satisfy the inclusion and exclusion criteria were 
included in the study after getting an informed consent from both the  
patients and  their husbands . 
INCLUSION CRITERIA 
1. All pregnant women who have completed 37 weeks of 
gestation and less than 42 weeks as assessed by menstrual dates, 
clinical examination and confirmed by doing an ultrasonagram. 
2. Cevical score  assessed by Bishop scoring with < 4. 
3. Prelabour rupture of membranes. 
4. Single fetus with Cephalic presentation. 
                5. Live fetus showing no compromise on admission   
Cardiotocogram.          .                                                             
EXCLUSION CRITERIA 
1. Bad obstetric history 
2. Multiple gestation 
 33
3. Women with PROM in labour 
4. Suspected chorioamnionitis 
5. Previous history of caesarean section or other uterine 
surgeries. 
6. Fetal distress , hydramnios or intrauterine growth 
restriction. 
7. Contraindications for prostaglandins such as bronchial 
asthma and allergy. 
8. Associated medical complications for the mother or 
gravida > 3. 
 After being included in the study they were randomly 
allocated to either prostaglandin E2 group or oxytocin group. 
The time of application of intracervical prostaglandin E2 or 
the time of starting the oxytocin infusion is taken as Zero hour.  
Patients name, age, parity, and duration of rupture of membranes are 
noted.  General ,abdominal  and vaginal examinations are done. 
Bishop’s score is assessed. 
All patients are monitored with partogram and amnioinfusion 
is given to all patients with amniotic fluid index less than six. 
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Patients in oxytocin group are given 5 milli units / minute 
diluted in normal saline or ringer lactate.  This is increased by six milli 
units / minute every 20 - 40 minutes until adequate uterine contractions 
are achieved namely three contractions per ten minutes each lasting 
45 seconds to a maximum dose of 40 milli units / minute. 
To patients in the prostaglandin E2 group, prostaglandin E2 
gel (dose 3 gram) 0.5mg available in a preloaded syringe is placed in 
the endocervical canal under strict aseptic precautions. A repeat dose 
of prostaglandin E2 gel is given to patients with no improvement in 
Bishop’s score after 6 hrs. In patients with improvement in Bishop’s 
score labour is augmented with oxtyocin infusion. 
Bishops score at 12 hrs and 24 hrs are assessed for all 
patients.  The duration of labour in stage I and stage II are tabulated.  
The induction delivery interval is calculated, any associated maternal 
complication is recorded. 
The weight and 5 minute apgar of all newborn delivered are 
tabulated, neonatal complications are also noted. 
Patients with non - progress of labour or fetal distress are 
taken up for lower segment caesarean section or forceps as indicated 
and labour outcome is recorded. 
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All parameters are tabulated and statistical analysis is done 
using graph pad instat - 3 software. P value of < 0.05 is taken as 
significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 36
The study includes a total of 400 patients; 200 each in 
oxytocin and prostaglandin group 
 
Table 1:Parity Distribution 
 
 
  
 
Out of these 50% were nulliparous and 50% were of para 1. 
 
Table 2:Age group distribution 
  
 
  
 
P=0.30 
 
The Age group distribution between the two groups were 
found to be comparable. There was no statistical difference between 
the age group of two groups (P=0.30). Majority of patients were in age 
group 21-25, 55% in oxytocin group and 57% in Prostaglandin E2 
group, followed by 26-30 age group in both the groups. 
 
Parity Oxytocin % Prostaglandin E2 % 
Nulliparous 100 50 100 50 
Para 1 100 50 100 50 
Age In 
Years 
Oxytocin % Prostaglandin E2 % 
<=20 22 11 38 19 
21-25 110 55 114 57 
26-30 64 32 44 22 
>30 4 2 4 2 
Mean 24.02  23.56  
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Table 3: Gestational age distribution 
 
Gestational Age Oxytocin % Prostaglandin E2 % 
>=37-38 98 49 96 48 
>38-40 102 51 104 52 
>40-42 - - - - 
Mean 38.16  38.18  
                  P=0.91 
 
The mean gestational age in oxytocin and prostaglandin 
groups are 38.16  and 38.18 weeks respectively. The number of 
patients in 38-40 weeks and 37-38 weeks in each group is almost 
equal. There is no significant difference in the gestational age of both 
groups (P=0.91). 
 
Table 4: Bishop score at Induction 
 
Bishop 
Score 
               Oxytocin Prostaglandin E2 
Nulliparous % Para 
1 
% Nulliparous % Para 
1 
% 
0-2 68 68 62 62 90 90 78 78 
3-4 32 32 38 38 10 10 22 22 
Mean 1.86  1.94  1.28  1.5  
               Nulliparous P=0.0156  Para 1 P=0.10 
 
A significant difference was noted in the Bishops score 
between both the groups for nulliparous patients (P-0.0156). The mean 
Bishops score is 1.86 in oxytocin group whereas it is 1.28 in 
prostaglandin group. 
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However in patients with Para-1 the Bishops score were not 
found to be statistically significant between the two groups (P-0.10).
 The mean Bishops score in oxytocin group is 1.94 compared to 
1.5 in prostaglandin E2 group. 
 
Table 5:Bishops score at 12 hours after induction  
 
 
Bishop 
Score 
               Oxytocin Prostaglandin E2 
Nulliparous % Para 
1 
% Nulliparous % Para 
1 
% 
0-3 40 40 22 22 20 20 10 10 
4-6 34 34 24 24 22 22 20 20 
7-9 20 20 40 40 38 38 40 40 
Mean 4.34  5.46  5.01  6.06  
             Nulliparous P=0.008  Para 1 P=0.01 
 
When Bishops score is assessed at 12 hrs after induction of 
labour a statistically significant difference was found between 
prostaglandin and oxytocin group in both nulliparous and para-1 
patients (P-0.008 and P-0.01 respectively). 
The mean Bishops score is 4.34 and 5.46 in oxytocin group 
for nulliparous and para-1 respectively whereas it is 5.01 and 6.06 in 
prostaglandin group, which is significantly higher. 
Hence prostaglandin was found to significantly improve 
Bishops score at 12hrs compared to oxytocin. 
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 Table 6: Mode of delivery 
 
                                         Oxytocin Prostaglandin E2 
Mode Of 
Delivery 
Nulliparous % Para 
1 
% Nulliparous % Para 
1 
% 
Labour 
Natural(
LN) 
62 62 74 74 80 80 86 86
LSCS 32 32 24 24 12 12 12 12
Forceps 6 6 2 2 8 8 2 2 
            LSCS-Lower Segment Caesarean Section 
 
            For LSCS Nulliparous P=0.028 Para 1 P=0.19 
            For  LN Nulliparous P=0.76 Para 1 P=0.19 
 
 
In oxytocin group 62% of nulliparous women and 74% of 
para-1 women delivered by spontaneous vaginal delivery, whereas in 
prostaglandin group 80% of Nulliparous women and 86% of para-1 
women delivered by spontaneous vaginal delivery. Though a higher 
percentage of women in prostaglandin group delivered as spontaneous 
vaginal delivery it was not found to be statistically significant 
(Nulliparous P-0.76 para-1 P-0.19). 
Thirty two percent of nulliparous women in oxytocin group 
and 24% of para-1 in oxytocin group required caesarean section 
whereas only 12% in both nulliparaous and para-1 women in 
prostaglandin group required caesarean section. The difference in 
Nulliparous women between the two groups was found to be 
statistically significant (P-0.028), but in para-1 women though a lesser 
 40
percentage of women in prostaglandin group required caesarean 
section,the difference was not statistically significant (P-0.19) 
 
Table – 7: Induction delivery interval  
 
 
Induction
-Delivery 
Interval 
               Oxytocin Prostaglandin E2 
Nulliparous % Para 
1 
% Nulliparous % Para 
1 
% 
<12 hrs 6 6 14 14 20 20 34 34 
12-24 hrs 28 28 42 42 44 44 48 48 
>24 hrs 36 36 18 18 24 24 6 6 
Mean  25.95  18.8  19  13.93  
Mean 
total 
22.23 16.44 
           Nulliparous P=0.0012 Para 1 P=0.004 
            Total P=<0.0001 
 
The induction delivery interval was >24hrs in 36% of 
nulliparous women and 12-24hrs in 42% in oxytocin group whereas in 
prostaglandin group the majority is in the 12-24hrs in both nulliparous 
and para-1 women with 44% and 48% respectively. 
The mean induction delivery interval is 25.95 hrs and 19hrs 
in oxytocin and prostaglandin group in nulliparous whereas para-1 
women the mean is 18.8hrs and 13.9hrs in both groups respectively. 
Thus the induction delivery interval is found to be significantly lower for 
both nulliparous and para-1 women in prostaglandin E2 group 
(nulliparous P-0.0012 and para-1 P-0.004). 
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Table-8: Indication for LSCS (Lower Segment Caesarean Section)  
 
Indication 
For 
Lscs  
               Oxytocin Prostaglandin E2 
Nulliparous % Para 
1 
% Nulliparous % Para 1 % 
Fetal 
Distress 
18 18 8 8 6 6 8 8 
Failed 
Induction 
14 14 16 16 6 6 4 4 
           Nulliparous P-0.0298  Para 1 P-0.1931 
 
In nulliparous group there is a statistically significant 
reduction in the need for caesarean section from 32% in oxytocin 
group to 12% in prostaglandin group. In para-1 group though there is a 
50% reduction in the incidence of caesarean section from 24% to 12% 
the difference is not statistically significant. 
 
Table  9: Birth Weight Distribution 
 
 
Birth Weight In 
Kilograms 
               Oxytocin Prostaglandin E2 
2-2.5 64 52 
2.5-3 88 96 
>3 48 52 
Mean 2.74 2.81 
            P=0.21 
 
The mean birth weight in oxytocin and prostaglandin E2 
group were 2.74 and 2.81kilograms respectively. There is no 
significant difference between 2 groups (P-0.21) . 
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Table  10:Neonatal Outcome 
 
 
Neonatal 
Outcome 
               Oxytocin Prostaglandin E2 
Apgar At 
5minutes <=5 
2 4 
Pathological 
Jaundice 
- - 
 
 
 In oxytocin group only 2 newborn had apgar ≤5 whereas in 
prostaglandin E2 group 4 babies had apgar ≤5. None of the babies had 
pathological jaundice in both the groups. 
 
Table  11: Maternal Complications 
 
 
Maternal 
Complications 
               Oxytocin Prostaglandin E2 
Atonic PPH 2 - 
Hypertonus - 2 
              PPH-Postpartum Haemorrhage 
 
Two  patient in oxytocin group had atonic PPH (Post partum 
Haemorrhage) whereas two had hypertonus in prostaglandin E2 group. 
No other maternal complications occurred. 
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In the present study the age group distribution was even 
between both the groups. The mean age in oxytocin group is 24.02 yrs 
whereas in prostaglandin group it is 23.56 yrs. This is similar to other 
studies where similar age group patients were included in both the 
groups. 
      In the present study 200 (50%) nulliparous and 200 (50%) 
para-1 patients were chosen  with prelabour rupture of membranes at 
term and were equally randomised into either oxytocin or prostaglandin 
group. 
Studies done by malik et al41  included 118 patients and that 
done by Trofatter et al18  included 538 patients,  Jackson et al 37 
included 158 women  and that by McCaul et al38 included 96 women. 
These studies included both nulliparous and para-1 patients similar to 
the present study whereas some studies were done exclusively on 
nulliparous women for example a study by chua et al 35 included 94 
nulliparous women  and study by Ekman-Ordenberg et al16 included 
only 20 nulliparous women  and study by Herabutya et al 36included 47 
nulliparous women and study by ulmsten et al17    included 100 
nulliparous women . 
The mean gestational age in the oxytocin group is 38.16 
weeks whereas it is 38.18 weeks in the prostaglandin group which is 
comparable. Studies done by chua et al 35, Ekman et al 16, Herabutya 
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et al 36 and ulmsten et al 17 all included term pregnant women 
comparable to the present study. 
However study done by Goeschen 23 and Bernstein et al 12 
included women with more than or equal to 36 weeks of gestation. 
In the present study women with bishop score less than or 
equal to 4 were included. In a study including 538 women by 
Trofatter18 similar to the present study bishop score with < or = 4 were 
included. Also studies done by Herabutya et al 24 and Bernstein et al 12  
included women with Bishops score < or = 4. However in study by 
Egarter et al 7 , Bredow et al 42 and Ashrafunnessa et al 19 included 
women with Bishops score < or = 5. Also study by Chua et al11 
included  women with bishop score with < or = 6 and study by 
Goeschen 23 included women with bishop score    < or = 7.  
In the present study there is a significant improvement in 
Bishops score in  both nulliparous and para-1 group at 12 hours after 
induction of labour in the prostaglandin group compared to oxytocin 
group. The Bishops score improved from mean of 1.28 in nulliparous 
group to 5.01 at 12hrs and from 1.5 to 6.06 in para-1 group for 
prostaglandin gel. In oxytocin group the bishop score improved from 
1.86 to 4.34 for nuliparous and from 1.94 to 5.46 in para-1 group. 
In a study by ulmsten et al 17 similar improvements in Bishop 
score from 2.9 to 6.3 was observed for prostaglandin gel application. 
Similarly in a study by Trofatter et al 18 significant improvement in 
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Bishops score was reported at 12 hours after induction. Study by 
Ashrafunnessa et al 19 also reported a significant improvement in 
bishop score with prostaglandin gel as compared to oxytocin . In a 
study by Bredow et al 8 the bishop score improved from 2.5 to 5.5 in 
prostaglandin group . Similar improvement in Bishops score was also 
reported by Bernstein et al 12. In a study by pollnow et al 27 
prostaglandin E2 gel was significantly better at achieving a change in 
Bishops score of 3 or more . 
However studies by Herabutya et al36 and Jackson et al37 
reported no significant improvement in Bishop score for prostaglandin 
gel as compared to oxytocin. 
In the present study the mean induction delivery interval for 
nulliparous oxytocin women is 25.95 hrs compared to 19hrs in 
nulliparous  prostaglandin women. In para-1 women the mean 
induction delivery for oxytocin group is 18.8 hrs compared to 13.93 hrs 
in prostaglandin group. The difference were significantly different. 
Hence prostaglandin is more efficacious in induction of labour. 
In study by ulmsten et al 17 in women with unfavourable 
cervix 53% delivered with PGE2 compared to 31% with oxytocin. In 
another study by Trofatter et al 18 prostaglandin significantly reduced 
the induction delivery interval . 
In study by Jackson et al 37 prostaglandin E2 gel treated 
patients were delivered sooner 20.2hrs compared to 25hrs in oxytocin 
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group. Study by Ashrafunnessa et al 19 also reported a significant 
reduction in induction delivery – interval with prostaglandin E2 gel. 
Papageorgiou et al 21 also reported a similar outcome. Atad et al 29 
also has reported similar outcome. 
However studies by Chua et al 35, Herabutya et al 36 and Mc 
Caul et al 38    reported no significant difference in the induction 
delivery interval between the oxytocin and prostaglandin E2 gel. 
In the present study 80% of nulliparous women in 
prostaglandin group delivered by labour natural compared to 62% in 
the oxytocin group. In para-1 it is 86% and 74% in prostaglandin and 
oxytocin group respectively. Though there is a trend of increased 
number of labour natural in prostaglandin E2 group, the results are not 
statistically significant. For caesarean section, in nullipara the 
incidence of caesarean section is 12% in prostaglandin group 
compared to 32% in oxytocin group which is statistically significant. In 
para-1 group though there is a reduction in caesarean section in 
prostaglandin group it is not statistically significant. 
 
In study by Trofatter 18 the incidence of caesarean section 
was found to be lower in prostaglandin group 28.5% vs 32.9% in 
control group but was not statistically significant.  In a study by 
Ashrafunnessa et al 19 the proportion of caesarean section was high in 
oxytocin group compared to prostaglandin group. 
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In a study by Vrtacnik–Bokal et al 25, the rate of caesarean 
section were 18.75% in the prostaglandin group compared to 29.41% 
in the oxytocin group. 
In a study by Bilgin et al 30 the incidence of caesarean 
section in the oxytocin group is 24% compared to 5% in the 
prostaglandin group. 
In studies done by Chua et al 35, Mc Caul et al 38, Herabutya 
et al  24and Pollnow et al 27 no significant difference were observed in 
the rate of caesarean section between the prostaglandin and oxytocin 
group. Also in the study by Magann et al 39the incidence of caesarean 
deliveries were found to be similar between oxytocin and prostaglandin 
group, with approximately 59% of pregnancies delivered abdominally. 
In the present study only 2 women in the prostaglandin 
group had hypertonus and 2 woman in the oxytocin group had 
postpartum haemorrhage. No other maternal complications were 
encountered. 
In study by ulmsten et al 17, no adverse maternal 
complication were noted during study period in both oxytocin and 
prostaglandin group. 
In study by Jackson et al 37, uterine hyperstimulation was 
reported in the prostaglandin group at a rate of 4.8% and Cabrol et al31 
reported signs of uterine hypercontractility in PGE2 group. 
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Studies done by Gonen et al 10, Goeschen 23, Bredow et al 8, 
Vrtacnik-Bokal et al 25, Pollnow et al 27 reported no significant 
difference in the incidence of maternal complications between the 
prostaglandin and oxytocin group. 
In a study by Malik et al 41 amnionitis developed in 5.3% of 
prostaglandin E2 group compared to 8% in oxytocin group. 
Endometritis developed in 1.7% of PGE2 group compared to 3.2% in 
oxytocin group though the results were not statistically significant. 
 
The mean birth weight  in oxytocin and prostaglandin E2 
group in the present study were 2.74kg and 2.81kg respectively. Also 
the 5 minute apgar was < or = 5 in 2 newborn in the oxytocin group 
and 4 newborn in the prostaglandin group. No other neonatal 
complications were encountered. 
Study by Chua et al 35 reported similar incidence of low 
apgar in oxytocin and prostaglandin group. Malik et al also reported no 
significant difference in the birth weight and 1 and 5 minute apgar 
score between oxytocin and prostaglandin group. 
Also studies done by Ulmsten et al 17, Trofatter et al 18, 
Ashrafunnessa et al 19, Goeschen 23,  Bredow et al 8 and Bilgin et al 30  
reported no significant difference in the neonatal outcome between the 
oxytocin and prostaglandin group. 
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One study by Papageorgiou et al 21 reported increased 
incidence of 5 min apgar < 7 in oxytocin group compared to 
prostaglandin E2 gel group (P < 0.05). 
Study by Meikle et al 44also reported no significant difference 
in infections between two groups. Study by Goeschen 23  reported a 
decreased incidence of neonatal infection in the prostaglandin E2 gel 
group. 
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• Majority of  patients included in the study were in 21-25 
age group. 
• The mean gestational age is 38.16 weeks  in oxytocin 
group and 38.18 weeks in the prostaglandin group. 
• Prostaglandin E2 gel causes a significant improvement in 
Bishops score compared to oxytocin in both Nulliparous and Para-1 
group (P-0.008 and P-0.01 respectively). 
• There is a non significant trend towards increased 
incidence of labour natural in prostaglandin group. 
• Prostaglandin E2 gel significantly reduces the incidence 
of caesarean section in nulliparous wowen from 32% in oxytocin group 
to 12% in prostaglandin E2 group. 
• There is a non significant trend in the reduction of 
caesarean sections in para-1 women from 24% in oxytocin group to 
12% in prostaglandin E2 group. 
• Prostaglandin E2 gel causes a significant reduction in 
mean Induction delivery interval compared to oxytocin. For nulliparous 
women the mean induction  delivery interval is 25.95hrs in oxytocin 
group compared to 19hrs in prostaglandin group. In para-1 women the 
mean induction delivery interval in oxytocin group is 18.8hrs compared 
to 13.93hrs in prostaglandin group. 
• There is low incidence of maternal complications in both 
oxytocin and prostaglandin group. 
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• The birth weight and Apgar score at 5 for neonates was 
comparable between both the groups, and the incidence of neonatal 
complication is extremely low. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 52
In the present study comparing prostaglandin E2  gel and 
oxytocin for induction of labour in prelabour rupture of membranes at 
term, prostaglandin E2 gel is found to significantly improve Bishops’s 
score at 12hrs compared to oxytocin in both nulliparous and para-1 
women. Prostaglandin also significantly reduces the induction delivery 
interval compared to oxytocin in both nulliparous and para-1 women. 
Prostaglandin gel causes reduction in the requirement of caesarean 
section especially in nulliparous women as compared to oxytocin. Also 
it is found that prostaglandin is safe and is not associated with any 
significant adverse effects for both the mother and the neonate. 
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